Response: Homocysteine lowering and recurrent venous thrombosis: the VITRO trial

Martin den Heijer; Henk J. Blom; Frits R. Rosendaal; Gerard M.J. Bos

doi:10.1182/blood-2007-02-075507

Related publications

Article2011

Malignancies and risk of recurrent venous thrombosis

J.F. Timp, Linda E. Flinterman, Astrid van Hylckama Vlieg, Frits R. Rosendaal, Suzanne C. Cannegieter

Article2014

The risk of recurrent venous thrombosis in patients with cancer

J.F. Timp, Linda E. Flinterman, Astrid van Hylckama Vlieg, Saskia le Cessie, Frits R. Rosendaal, Suzanne C. Cannegieter

Thrombosis Research

Article2016

Homocysteine levels and risk of first venous thrombosis: the influence of (unmeasured) confounding factors

Monica Ospina‐Romero, Willem M. Lijfering, Suzanne C. Cannegieter, Frits R. Rosendaal, Martin den Heijer, Carine J.M. Doggen

Letter2012

The influence of prothrombotic laboratory abnormalities on the risk of recurrent venous thrombosis

Daniel Dias Ribeiro, Willem M. Lijfering, Sandhi Maria Barreto, Fabiane Dias Lopes, Giselli de Souza Pires, Frits R. Rosendaal, Suely Meireles Rezende

Thrombosis Research

Article2013

Predictive value of high factor VIII levels for recurrent venous thrombosis

J.F. Timp, W.M. Lijfering, Linda E. Flinterman, Astrid van Hylckama Vlieg, Frits R. Rosendaal, Suzanne C. Cannegieter

Journal of Thrombosis and Haemostasis